At the end of the latest market close, KemPharm Inc. (KMPH) was valued at $12.48. In that particular session, Stock kicked-off at the price of $12.60 while reaching the peak value of $13.84 and lowest value recorded on the day was $12.35. The stock current value is $13.35.
Recently in News on June 9, 2021, KemPharm to be Added to Russell 2000® and Russell 3000® Indexes Effective June 28, 2021. KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its expected addition to the broad-market Russell 3000® Index and the Russell 2000® Index in accordance with the 2021 Russell indexes annual reconstitution. KemPharm’s anticipated inclusion in the Russell indexes will be effective after the U.S. market opens on Monday, June 28, 2021. You can read further details here
KemPharm Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.15 on 03/03/21, with the lowest value was $5.07 for the same time period, recorded on 01/08/21.
KemPharm Inc. (KMPH) full year performance was 318.71%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, KemPharm Inc. shares are logging -39.54% during the 52-week period from high price, and 360.98% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.90 and $22.08.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1483979 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the KemPharm Inc. (KMPH) recorded performance in the market was 19.20%, having the revenues showcasing 33.77% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 373.13M, as it employees total of 22 workers.
The Analysts eye on KemPharm Inc. (KMPH)
During the last month, 0 analysts gave the KemPharm Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 9.40, with a change in the price was noted +7.39. In a similar fashion, KemPharm Inc. posted a movement of +123.99% for the period of last 100 days, recording 2,985,429 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for KMPH is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of KemPharm Inc. (KMPH)
Raw Stochastic average of KemPharm Inc. in the period of last 50 days is set at 91.27%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 91.03%. In the last 20 days, the company’s Stochastic %K was 92.92% and its Stochastic %D was recorded 94.13%.
Considering, the past performance of KemPharm Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 19.20%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -7.29%, alongside a boost of 318.71% for the period of the last 12 months. The shares increased approximately by 20.27% in the 7-day charts and went down by 52.92% in the period of the last 30 days. Common stock shares were driven by 33.77% during last recorded quarter.